Found 42 results
Filters: Author is Kovanlikaya, Ilhami  [Clear All Filters]
2019
Zhang S, Liu Z, Nguyen TD, Yao Y, Gillen KM, Spincemaille P, Kovanlikaya I, Gupta A, Wang Y.  2019.  Clinical feasibility of brain quantitative susceptibility mapping.. Magn Reson Imaging. 60:44-51.
Spincemaille P, Liu Z, Zhang S, Kovanlikaya I, Ippoliti M, Makowski M, Watts R, de Rochefort L, Venkatraman V, Desmond P et al..  2019.  Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness.. J Neuroimaging. 29(6):689-698.
Seligman L, Kovanlikaya I, Pisapia DJ, Naeger DM, Magge R, Fine HA, Chiang GC.  2019.  Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.. AJR Am J Roentgenol. 212(4):883-891.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.. Magn Reson Imaging. 57:254-258.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas.. Eur Radiol. 29(6):2751-2759.